| Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 SM Abraham, T Lawrence, A Kleiman, P Warden, M Medghalchi, ... The Journal of experimental medicine 203 (8), 1883, 2006 | 491 | 2006 |
| Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38 M Lasa, SM Abraham, C Boucheron, J Saklatvala, AR Clark Molecular and cellular biology, 2002 | 483 | 2002 |
| Dual-specificity phosphatase 1: a critical regulator of innate immune responses SM Abraham, AR Clark Biochemical Society Transactions 34 (6), 1018-1023, 2006 | 186 | 2006 |
| Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo … S Abraham, HB Juel, P Bang, HM Cheeseman, RB Dohn, T Cole, ... The Lancet infectious diseases 19 (10), 1091-1100, 2019 | 181 | 2019 |
| Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway S Alzabin, SM Abraham, TE Taher, A Palfreeman, D Hull, K McNamee, ... Annals of the rheumatic diseases 71 (10), 1741-1748, 2012 | 165 | 2012 |
| Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis E Pathan, S Abraham, E Van Rossen, R Withrington, A Keat, PJ Charles, ... Annals of the rheumatic diseases 72 (9), 1475-1480, 2013 | 161 | 2013 |
| Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical … M Al-Laith, M Jasenecova, S Abraham, A Bosworth, IN Bruce, CD Buckley, ... Trials 20, 1-15, 2019 | 103 | 2019 |
| The evidence for microbiome manipulation in inflammatory arthritis H Jethwa, S Abraham Rheumatology 56 (9), 1452-1460, 2017 | 73 | 2017 |
| Microflow imaging: New Doppler technology to detect low-grade inflammation in patients with arthritis AKP Lim, K Satchithananda, EA Dick, S Abraham, DO Cosgrove European Radiology 28, 1046-1053, 2018 | 63 | 2018 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 60 | 2019 |
| Quantitative power Doppler ultrasound measures of peripheral joint synovitis in poor prognosis early rheumatoid arthritis predict radiographic progression D Sreerangaiah, M Grayer, BA Fisher, M Ho, S Abraham, PC Taylor Rheumatology 55 (1), 89-93, 2016 | 52 | 2016 |
| Dual‐specificity phosphatase 1–null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis Y Vattakuzhi, SM Abraham, A Freidin, AR Clark, NJ Horwood Arthritis & Rheumatism 64 (7), 2201-2210, 2012 | 46 | 2012 |
| Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis DN Hull, RO Williams, E Pathan, S Alzabin, S Abraham, PC Taylor Clinical & Experimental Immunology 181 (3), 401-406, 2015 | 40 | 2015 |
| Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis DN Hull, H Cooksley, S Chokshi, RO Williams, S Abraham, PC Taylor Arthritis research & therapy 18, 1-12, 2016 | 36 | 2016 |
| Telemedicine in rheumatology at the advent of the COVID-19 pandemic E Gkrouzman, DD Wu, H Jethwa, S Abraham HSS Journal® 16 (1_suppl), 108-111, 2020 | 35 | 2020 |
| Point of care testing of phospholipase A2 group IIA for serological diagnosis of rheumatoid arthritis NJ Liu, R Chapman, Y Lin, J Mmesi, A Bentham, M Tyreman, S Abraham, ... Nanoscale 8 (8), 4482-4485, 2016 | 25 | 2016 |
| Covid-19 vaccine trials: Ethnic diversity and immunogenicity H Jethwa, R Wong, S Abraham Vaccine 39 (27), 3541-3543, 2021 | 24 | 2021 |
| Artificial intelligence (AI) and rheumatology: a potential partnership S Kothari, L Gionfrida, AA Bharath, S Abraham Rheumatology 58 (11), 1894-1895, 2019 | 19 | 2019 |
| The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway N Ambrose, E Khan, R Ravindran, L Lightstone, S Abraham, M Botto, ... Clinical & Experimental Immunology 181 (3), 427-433, 2015 | 19 | 2015 |
| Good practice in shared care for inflammatory arthritis MP Lythgoe, S Abraham British Journal of General Practice 66 (646), 275-277, 2016 | 17 | 2016 |
